✦ LIBER ✦

Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study

✍ Scribed by Ostenfeld, T.; Krishen, A.; Lai, R.Y.; Bullman, J.; Baines, A.J.; Green, J.; Anand, P.; Kelly, M.

Book ID: 120936337
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 485 KB
Volume: 17
Category: Article
ISSN: 1090-3801
DOI: 10.1002/j.1532-2149.2012.00256.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the p38 MAPK inhi

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

✍ Watz, Henrik; Barnacle, Helen; Hartley, Benjamin F; Chan, Robert 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 405 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

✍ Michael C. Rowbotham; W. Rachel Duan; James Thomas; Wolfram Nothaft; Misha-Miros 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

✍ Stanley B. Cohen; Tien-Tsai Cheng; Vishala Chindalore; Nemanja Damjanov; Ruben B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

A 24-Week, Randomized, Double-Blind, Pla

A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis

✍ Genovese, Mark C. (author);Cohen, Stanley B. (author);Wofsy, David (author);Wein 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 320 KB

A 24-Week, Randomized, Double-Blind, Pla

✍ Genovese, Mark C. (author);Cohen, Stanley B. (author);Wofsy, David (author);Wein 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 320 KB

Efficacy and safety of monotherapy with

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

✍ Kaku, Kohei; Watada, Hirotaka; Iwamoto, Yasuhiko; Utsunomiya, Kazunori; Terauchi 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 316 KB